Everything is connected: social determinants of pediatric health and disease

Carine Tarazi1, Margie Skeer2, Kevin Fiscella3,4,5

  • 1International Pediatric Research Foundation, The Woodlands, Texas.

Pediatric Research
|February 4, 2016
PubMed

Insights

This research highlights the critical roles of guest editors in shaping special issues for Pediatric Research. Their expertise guides the focus on adolescent health, health equity, and perinatal neuroepidemiology, advancing scientific discourse.

Area of Science:

  • Public Health and Community Medicine
  • Pediatrics
  • Family Medicine
  • Ophthalmology
  • Perinatal Neuroepidemiology

Background:

  • Guest editors bring specialized knowledge to focused research areas.
  • Adolescent substance misuse and sexual risk prevention are key research areas.
  • Health disparities and strategies for health equity are critical concerns.

Discussion:

  • The integration of epidemiologic and intervention-development perspectives is crucial.
  • Computational models aid in understanding chronic disease development.
  • Risk and causation theories are fundamental to biomedical and public health research.

Key Insights:

  • Expert guest editors enhance the quality and impact of special journal issues.
  • Multidisciplinary collaboration drives innovation in pediatric research.
  • Addressing health disparities requires practical, evidence-based strategies.

Outlook:

  • Future research will likely focus on computational approaches to chronic disease.
  • Continued emphasis on preventing adolescent risk behaviors is essential.
  • Improving health equity in pediatric populations remains a priority.

Related Concept Videos

Dimensions of Health and Illness01:21

Dimensions of Health and Illness

The factors influencing the health-illness continuum can be internal or external and may or may not be under conscious control. They are related to the following eight human dimensions, and each dimension is interrelated to one other.
11.9K
Factors Affecting Illness01:18

Factors Affecting Illness

When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
5.6K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
458
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
693
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
327
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
726